Invasive Aspergillosis
3 competing products in clinical development for Invasive Aspergillosis.
Pipeline by Phase
Phase 21
Phase 31
Approved1
All Products (3)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Olorofim + AmBisome® | Shionogi | Phase 3 | Active | 44 |
| Micafungin | Astellas Pharma | Approved | Terminated | 35 |
| Micafungin + Systemic antifungal therapy | Astellas Pharma | Phase 2 | Terminated | 27 |